Investing.com - Benitec Biopharma ADR reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that was in line with expectations.
Benitec Biopharma ADR announced earnings per share of $-0.470 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.290 on revenue of $0.00.
Benitec Biopharma ADR shares are down 4.96% from the beginning of the year, still down 95.68% from its 52 week high of $3.66 set on November 10, 2021.
Benitec Biopharma ADR shares gained 5.99% in intra-day trade following the report.
Benitec Biopharma ADR follows other major Healthcare sector earnings this month
Benitec Biopharma ADR's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar